StockTipsArenaBeta

BUY Glenmark Pharmaceuticals — Prakash Gaba

BUYGlenmark Pharmaceuticals
Glenmark Pharmaceuticals share price target & all analyst calls

byPrakash GabaHorizon: NA (inferred Intraday)12 Aug 2026, 10:02 am ISTvia CNBC Awaaz.

Entry₹2,287.4Inferred
Target₹2,320
Total upside +1.43% (call closed)
Stop loss₹2,280-0.32% risk
Exit₹2,28012 Aug 2026, 12:27 pm
Stop-loss hit-0.32%
Follow Prakash Gaba for new calls(20% target hit, 382 closed calls)Get alertsWatch GLENMARK for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 12 Aug 2026
1 supporting1 neutral1 opposing
Supports the BUY call (1)

3 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·12 Aug · today

Neutral / worth noting (1)

Glenmark USA has agreed to a settlement of $15.28 million to resolve antitrust and consumer protection lawsuits related to price-fixing allegations. The company denies all allegations and states the s

BSE · Company Update·11 Aug · today

(opens in new tab)
Weighs against the BUY call (1)

Glenmark Pharma US arm agrees to $15.28 million settlement with Humana over antitrust lawsuits

NewsCnbc-Tv18·12 Aug · today

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Glenmark Pharmaceuticals

All analyst calls on Glenmark Pharmaceuticals

More from Prakash Gaba

Every call and its outcome